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AbstrACt
Objective To adapt and validate a questionnaire 
originally developed in a research setting for assessment 
of comprehension of consent information in a different 
cultural and linguistic research setting.
Design The adaptation process involved development 
and customisation of a questionnaire for each of the three 
study groups, modelled closely on the previously validated 
questionnaire. The three adapted draft questionnaires were 
further reviewed by two bioethicists and the developer of 
the original questionnaire for face and content validity. The 
revised questionnaire was subsequently programmed into 
an audio computerised format, with translations and back 
translations in three widely spoken languages by the study 
participants: Luo, Swahili and English.
setting The questionnaire was validated among 
adolescents, their parents and young adults living in Siaya 
County, a rural region of western Kenya.
Participants Twenty-five-item adapted questionnaires 
consisting of close-ended, multiple-choice and open-
ended questions were administered to 235 participants 
consisting of 107 adolescents, 92 parents and 36 young 
adults. Test-retest was conducted 2–4 weeks after first 
questionnaire administration among 74 adolescents, young 
adults and parents.
Outcome measure Primary outcome measures included 
ceiling/floor analysis to identify questions with extremes 
in responses and item-level correlation to determine 
the test-retest relationships. Given the data format, 
tetrachoric correlations were conducted for dichotomous 
items and polychoric correlations for ordinal items. The 
qualitative validation assessment included face and 
content validity evaluation of the adapted instrument by 
technical experts.
results Ceiling/floor analysis showed eight question 
items for which >80% of one or more groups responded 
correctly, while for nine questions, including all seven 
open-ended questions,<20% responded correctly. Majority 
of the question items had moderate to strong test-retest 
correlation estimates indicating temporal stability.
Conclusions Our study demonstrates that cross-
cultural adaptation and validation of an informed consent 
comprehension questionnaire is feasible. However, further 
research is needed to develop a tool which can estimate a 
quantifiable threshold of comprehension thereby serving 
as an objective indicator of the need for interventions to 
improve comprehension.
IntrODuCtIOn  
Informed consent is a key ethical require-
ment in clinical research. Universally agreed 
guidelines highlight four elements of 
informed consent which normally must be 
satisfied before proceeding with the conduct 
of scientific research involving human partic-
ipants. These elements include decisional 
competence, disclosure of study informa-
tion, comprehension and voluntariness.1–4 Of 
these elements, comprehension of consent 
information by a prospective research partic-
ipant is critical to the quality of a consent 
procedure as it determines how the partici-
pant is empowered to use the information to 
arrive at an informed decision on whether 
or not to participate in the study.5 The 
informed consent process is typically built 
on the notion that individuals considering 
participation have demonstrated satisfactory 
understanding of the consent information.6 
strengths and limitations of this study
 ► We conducted a cross-cultural adaptability and vali-
dation study of an informed consent comprehension 
tool developed in two differently diverse linguistic 
settings
 ► Item-level test-retest reliability, as well as qualitative 
methods involving face and content validity, were 
employed to establish reliability and validity of the 
adapted tool.
 ► Relatively small sample size and disparate modes 
of parental consenting posed a unique challenge in 
validating a tool across many age groups.
 ► Our tool did not focus on developing a quantifiable 
threshold of comprehension below which the con-
sent of participants is invalidated.
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However, empirical evidence has shown that research 
participants frequently do not understand significant 
aspects of the studies they join, such as the difference 
between participating in clinical research and receiving 
medical care, that is, ‘therapeutic misconception'.7 They 
also demonstrate poor understanding of the concepts of 
randomisation, research risk and benefits and right of 
withdrawal.8–10 
Very few studies have assessed research participant 
comprehension of consent information in African 
populations. In a systematic review with meta-analysis of 
21 studies conducted across several African countries, 
comprehension of key concepts of informed consent 
was poor, with less than half of the study participants 
demonstrating understanding of research concepts such 
as randomisation and placebo, and with only 30% being 
aware of participating in clinical research.11 Conversely, 
another systematic review focusing on 103 studies 
conducted mainly in middle-income and high-income 
countries over a period of 30 years, showed that more 
than 70% of participants had good understanding of 
different domains of informed consent including nature 
of the study, voluntary participation and rights of with-
drawal, while appreciable proportions of the participants 
demonstrated no therapeutic misconceptions and were 
aware of the study risks and benefits.12
This contrast between the ideals of informed consent 
and the reality of informed consent in practice is espe-
cially marked in settings with high illiteracy rates or 
mistrust of research institutions, or where signatures are 
rarely employed for transacting business. Overemphasis 
on written documents can further aggravate these chal-
lenges to effective communication, particularly when 
participants are asked to understand complex informa-
tion contained in lengthy informed consent documents 
written in international languages with unfamiliar terms 
and concepts.13
To ensure participants make meaningful decisions that 
protect their rights and freedom of choice, researchers 
in socially and economically disadvantaged communi-
ties have been advised to make efforts to help prospec-
tive participants attain satisfactory understanding of 
informed consent.2 To help achieve this, a context-sensi-
tive tool is required to assess participant comprehension 
of components of consent information delivered during 
an informed consent discussion. The tool would help to 
indicate areas of miscomprehension and could further 
serve as a platform to develop appropriate interventions 
to improve the identified areas which participants do not 
understand.
The development and psychometric evaluation of a 
Digitised Informed Consent Comprehension Question-
naire (DICCQ) has been reported elsewhere.14 Briefly, the 
tool was developed following meticulous identification of 
domains of informed consent which are poorly under-
stood by research participants in low literacy communi-
ties in Africa. Owing to the peculiar challenge of inability 
to read and comprehend informed consent written in 
international languages, the questionnaire was developed 
into an audio computerised tool in the participants’ local 
languages. The tool was administered to assess the under-
standing of individuals participating in studies taking 
place in rural and urban settings of The Gambia, a small 
West African country characterised with an adult literacy 
rate of less than 50%.15 Although the tool was reported 
to be a reliable and valid measure of informed consent 
comprehension,14 we expressed concerns regarding 
whether the tool would retain its acceptable properties if 
adapted for use in alternate African settings with diverse 
cultural and linguistic variations.
Given that empirical assessment of consent compre-
hension is in its infancy and that instrument develop-
ment and validation are a lengthy but critical process, 
we focus on the cultural adaptation and evaluation of 
the DICCQ among a diverse population of adolescents, 
young adults and parents in a rural setting in western 
Kenya, East Africa. The initial validation of the DICCQ 
has been previously published,14 and is the basis for the 
instrument which was modified for relevance and tested 
among the three age groups in Kenya. This work is part 
of a study on the effects of HIV test disclosure on adoles-
cent behaviour and well-being to inform guidelines for 
the ethical conduct of adolescent HIV-related research in 
sub-Saharan Africa. Along with HIV testing, we are inves-
tigating comprehension during the informed consent 
process among parents and youth. The current paper 
focuses on the first phase of activities to assess informed 
consent comprehension. The activities included the adap-
tation of the DICCQ instrument, which was developed 
for adults, for use among adolescents and their parents, 
as well as young adults, content validation, ceiling-floor 
analysis and a test-retest assessment of the adapted instru-
ment. Results will be used to determine the final format 
of the adapted instrument.
the original DICCQ: constructs and validation
As highlighted above, the question items on the DICCQ 
were generated from basic elements of informed consent 
obtained from literature on guidelines for contextual 
development of informed consent tools,13 16–24 interna-
tional ethical guidelines3 25 and operational guidelines 
from The Gambia’s National Ethics Committee.26 Of 
these, 15 independent domains of informed consent 
that were not appropriately understood among study 
participants in low literacy settings were identified. 
These domains included voluntary participation, rights 
of withdrawal, study knowledge, study procedures, study 
purpose, blinding, confidentiality, compensation, rando-
misation, autonomy, meaning of giving consent, benefits, 
risks/adverse effects, therapeutic misconception and 
placebo.
DICCQ was face-validated by a carefully selected panel 
of researchers with expertise in research methodology 
and bioethics in the African context. The panel assessed 
the tool’s readability, clarity of words used, consistency 
of style and likelihood of target participants being able 
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to answer the questions. This same expert panel also 
assessed content validity to establish whether the content 
of the questionnaire was appropriate and relevant to the 
context for which it was developed.27 The tool was revised 
based on the feedback from these experts. The revised 
questionnaire was further content-validated by randomly 
selected research assistants and three independent lay 
persons to assess clarity and appropriateness of the revised 
question items and their response options.
Given the lack of acceptable systems of writing in 
Gambian local languages, the question items were 
audio recorded in three major local languages by expe-
rienced native-speaking linguistic professionals who 
were also familiar with clinical research concepts. 
Audio back-translations were done for each language 
by three independent native speakers and corrections 
were made in areas where translated versions were not 
consistent with the English version. A final proof of the 
audio recordings was conducted by three native-speaking 
clinical researchers who independently confirmed that 
the translated versions retained the original meaning of 
the English version.
The revised questionnaire was developed into an audio 
computer-assisted self-interview (ACASI) format and 
referred to as the DICCQ.14 The tool was administered to 
250 participants in two studies taking place concurrently 
in rural and urban Gambian settings. Half of these partic-
ipants were recalled in 1–2 weeks after the first adminis-
tration for a retest. Previously published findings showed 
that the DICCQ had good psychometric properties with 
potential as a useful tool for measuring comprehension 
of informed consent among research participants in 
low-literacy African settings.14
For the present study, we adapted the DICCQ for three 
groups: minor adolescents (15–17 years), their parents 
and young adults (18–19 years). Although some ques-
tions could be considered generic for research studies 
(such as voluntary participation, confidentiality and 
rights of withdrawal), others are specific and required 
adaptation (such as purpose of the study, benefits and 
risks). For minor adolescents and their parents, questions 
related to voluntary participation also required adapta-
tion for comprehension of concepts related to adolescent 
assent and parental permission. In this paper, we describe 
our validation methods and results, provide the resulting 
surveys, and discuss issues related to the assessment of 
comprehension of study information by participants 
in rural sub-Saharan settings. We refer to the adapted 
questionnaire as the Informed Consent Comprehension 
Assessment (ICCA).
MethODs
Validation sample
At the start of the parent study, we invited all consented 
participants from 10 randomly selected village clusters 
in one subcounty within Siaya County to respond to 
the ICCA. The first 235 to agree comprised the ICCA 
validation sample. Sample size for validation studies is 
usually determined with the aim of minimising the stan-
dard error (SE) of the correlation coefficient for reli-
ability test. Also, 4–10 subjects per question items are 
recommended to obtain a sufficient sample size in order 
to ensure stability of the variance-covariance matrix in 
factor analysis.28 29 We used these recommendations to 
determine our sample size.
The validation sample included minor adolescents 
(n=107), their parents (n=92) and young adults (n=36). 
Parents were invited if their adolescent child (or children) 
was selected for the ICCA Study. More than half of the 
parents (n=49) who took the ICCA were not consented 
by staff but rather signed a consent form that their adoles-
cent brought home to them.
Adaptation and validation procedures
We began our adaptation process by developing an ICCA 
questionnaire for each of the three groups, modelled 
closely on the DICCQ. We then customised two ques-
tions for minor adolescents about voluntary participation 
(ie, need for parental permission for participation and 
adolescents’ rights to refuse). For parents, questions were 
adapted as needed to refer to their child as the main study 
participant. Finally, questions with study-specific content 
were developed, using content from Instituitional Review 
Board (IRB)- approved consent forms. The three draft 
adapted questionnaires were then reviewed by two bioeth-
icists and the developer of the original DICCQ for face 
and content validity, based on study protocols and the US 
federal regulations.4 Suggestions to clarify language and 
responses from this expert review were incorporated into 
the second draft.
The revised questionnaire was then programmed for 
the ACASI format, with translations and back-translations 
in three languages (Luo, Swahili and English). Next, we 
conducted pilot tests of the questionnaires with local 
Kenyan parent and youth advisory group members30 to 
determine whether consent form information and ICCA 
items were consistent/non-contradictory. After each of 
the three groups (minor adolescents, young adults and 
parents) completed the appropriate version of ICCA, 
we asked participants, individually and in separate focus 
groups, for their opinions about the consent form, ICCA 
questions, administration of the ICCA using the ACASI 
format, and staff assistance (if requested) to type in 
responses to the open-ended questions. Based on feed-
back from participants, we revised the wording of one 
question’s response categories, dropped one question 
and revised the consent form to more clearly describe all 
aspects covered in ICCA.
Subsequently, we administered ICCA to our validation 
sample 2–4 weeks after consent and immediately prior to 
the baseline data collection. Adolescents who consented 
with the parent-child form took the Adolescent ICCA; 
those who consented with the young adult form took 
the Young Adult ICCA; and parents took the Parent 
ICCA. Following recommended guidelines in validation 
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studies,28 29 a subset of the sample, n=74, was retested 1–2 
weeks later for test-retest analyses. To make the procedure 
objective, participant selection for the retest was sequen-
tial (every second person), stratified by study site. If one 
refused, staff continued with the sequence (ie, skipping 
the next eligible and selecting the following).
Instrumentation
Each ICCA survey consisted of a set of 25 yes/no, multi-
ple-choice and open-ended questions. Responses to the 
yes/no and multiple-choice questions were coded 0–1 for 
incorrect/correct answers, respectively. Responses to the 
open-ended questions were independently coded from 
completely incorrect to completely correct (0–4) by a 
panel of three researchers who discussed their scores and, 
if different, came to a consensus on a single score per 
case. Responses were also dichotomised (0–1=incorrect; 
2–4=correct) for ceiling/floor analysis. The three survey 
tools (Adolescent, Young Adult and Parent) were gener-
ally similar. However, only seven questions and response 
options were identical across the three samples. Sixteen 
additional items were identical for adolescents and young 
adults. Two items were adolescent-specific, two were 
young adult-specific and 18 items were parent-specific. In 
addition to the questions on comprehension of informed 
consent, the ICCA also included sociodemographic items.
ethical considerations
Written informed parent/guardian consent and 
youth assent was obtained for adolescents younger 
than 18 years old; individuals who were 18 years 
or older or emancipated minors provided written 
informed consent. Participation was voluntary 
and private.
Patient and public involvement
To ensure the development of the research questions and 
outcome measures informed the study participants’ prior-
ities, experience and preferences, the adapted question-
naires were translated into the preferred local languages 
of the study participants. Given the technical complexity 
involved in designing the study, the study participants 
were not directly involved in this stage. Nevertheless, 
parent, professional and adolescent advisory committees 
reviewed all study plans and provided comments. Also, 
feedback obtained from pilot participants residing in 
the study area was used to refine the ICCA instruments. 
We had a team of dedicated staff that was responsible for 
the recruitment and conduct of the study; the partici-
pants were not involved in these processes. There are no 
plans to organise a feedback forum where the findings 
reported in this paper will be disseminated to the study 
participants and other stakeholders. However, findings 
from the larger parent study will be disseminated to key 
stakeholders in the study region, including members of 
our adult community advisory board and youth advisory 
board. 
Validation and reliability data analysis
All analyses were conducted using Stata V.13.0 
(StataCorp, College Station, Texas, USA). First, we 
conducted descriptive statistics to determine the magni-
tude of missing data in each of the ICCA items as well as 
questions with extremes in responding, that is, to which 
more than 80% in any one group responded correctly 
or incorrectly (ceiling/floor analyses). Because high 
comprehension is desirable for ethical consent, we were 
particularly interested in questions which fewer than 20% 
of the sample answered correctly, since this may indicate 
a problem in wording, format or translation, as well as 
comprehension.
Second, we conducted test-retest analysis to assess 
temporal stability of the ICCA questions, that is, whether 
they were reliable in eliciting the same response at 
initial presentation (test) and at the second presenta-
tion 1–2 weeks later (retest). Item-level correlations were 
examined to determine the test-retest relationships. 
Due to the data format, tetrachoric correlations were 
conducted for dichotomous items and polychoric correla-
tions were conducted for ordinal items (open-ended 
scores) with the user-created polychoric package.31 We 
used the following benchmarks to interpret the correla-
tion coefficients: below 0.5 was considered low, 0.5 to 
0.69 was moderate, and 0.7 and higher was strong. We 
interpreted moderate and strong correlation coefficients 
as indicating acceptable temporal stability. Post hoc anal-
yses, specifically cross-tabulations of participant responses 
at test and re-test, were conducted to further explore low 
correlations and to examine relationships in the data 
where correlation coefficients could not be obtained.
results
Table 1 shows the demographics of the validation sample, 
including age, gender, religion and the relationship 
between the adolescent and the person who gave permis-
sion for the adolescent to join the study. As can be seen, 
about 71% of adults who gave permission for adolescent 
study participation identified as parents.
Descriptive analyses showed that there were no ques-
tions with more than 5% missing data. The item with the 
largest percentage amount of missing responses (4%) 
was the open-ended study risk question (Are there any bad 
things that could happen by taking part in this study? If yes, 
what are they?). Ceiling/floor analysis showed eight ques-
tions for which >80% of one or more groups responded 
correctly, while for nine questions, <20% responded 
correctly (table 2). All seven open-ended questions were 
among the latter category.
As shown in table 3, the great majority of items, when 
analysed within groupings of the same wording, had 
moderate to strong test-retest correlation estimates, 
despite small sample size, suggesting temporal stability. 
These included all seven items with identical question 
and response wording for the entire test-retest sample 
(n=74); 12 of the 16 items with identical question wording 
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and response options for young adults and adolescents 
(n=45); one of the two questions specific to adolescents 
(n=33); and 10 of the 18 questions specific to parents 
(n=29). Seven items, however, had low correlations, while 
eight could not be estimated because of small sample 
sizes and/or near perfect correlation.
Three of the 16 items with identical question/response 
wording for young adults and adolescents had low 
correlation coefficients ranging between 0.19 and 0.47. 
Of these, one was the open-ended item, ‘What will you 
be asked to do as a participant in the study after you receive 
your HIV test results?’ In cross-tabulation, 34 participants 
(77%) gave the same response at test and retest while, 
6 answered correctly at test and incorrectly at retest. For 
the item, ‘What does it mean when you sign the study consent 
form?’ 26 (58%) gave the same answer at test and retest, 
while 3 answered correctly at test and incorrectly at retest. 
For the item, ‘Which describes the main benefit of taking part 
in the study?’ 34 participants (75%) gave the same answer 
at both test and retest, while 7 answered incorrectly at test 
and correctly at retest. Finally, a correlation coefficient 
could not be obtained for the item ‘Will you be told your 
HIV test results during the study?’ because of a lack of vari-
ation at retest, with 41 (91%) and 45 (100%) answering 
correctly at test and retest, respectively.
Of the two items that were specific to adolescents, one 
had a low correlation coefficient, ‘If your parents want you 
to join the study, but you do not want to, are you still allowed to 
refuse?’ For this item, 22 (67%) participants gave the same 
response at test and retest, while 10 answered incorrectly 
at test and correctly at retest. Correlations for both items 
specific to young adults could not be run, but cross-tab-
ulations revealed that all answered the question, ‘Have 
you been told that you can freely decide whether you will take 
part in this study?’ correctly at both test and retest. For the 
question, ‘How did you decide to join the study?’ 10 (83%) 
answered correctly at test, while all 12 answered correctly 
at retest.
Of the 18 items with question wording and/or response 
options specific to parents, three had low correlation coef-
ficients. For the item ‘How did you decide that you and your 
child would join this study?’ 18 participants (62%) gave the 
same response at test and retest while 8 (28%) answered 
correctly at retest only. Similarly, for the item, ‘If your child 
Table 1 Demographic characteristics of study participants, Kenya, 2017
Demographics Adolescents Young adults Parents
Age
  Median 16 18 42
  Range 15–17 18–19 23–95
  IQR 15–16 18–19 34–53
Gender
  Male 60 (56.1%) 18 (50%) 22 (23.9%)
  Female 47 (43.9%) 18 (50%) 70 (76.1%)
Currently enrolled in school: N (%) 105 (98.1%) 26 (72.2%) N/A
Highest level of education: N (%)
  Never gone to school 0 (0%) 0 (0%) 6 (6.5%)
  Did not complete primary (<Std/Class 8) 72 (67.3%) 5 (13.9%) 37 (40.2%)
  Completed primary (Std/Class 8) 10 (9.3%) 7 (19.4%) 24 (26.1%)
  Did not complete secondary (<Form 4) 25 (23.4%) 24 (66.7%) 10 (10.9%)
  Completed secondary (Form 4) 0 (0%) 0 (0%) 12 (13.0%)
  College or university 0 (0%) 0 (0%) 3 (3.3%)
Attended vocational school: N(%) 0 (0%) 2 (5.6%) 12 (13.0%)
Religion: N(%)
  Roman Catholic 16 (15.0%) 4 (11.1%) 16 (17.4%)
  Protestant/other Christian 90 (84.1%) 31 (86.1%) 76 (82.6%)
  Muslim 0 (0%) 1 (2.8%) 0 (0%)
  No religion 1 (0.9%) 0 (0%) 0 (0%)
Attending religious services once/week or more: N (%) 39 (36.4%) 20 (55.6%) 52 (56.5%)
Relationship with adolescent: N(%)
  Parent N/A N/A 65 (70.7%)
  Other N/A N/A 27 (29.3%)
Staff present at consenting: N(%) N/A N/A 43 (46.7%)
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tests positive for HIV, will he or she be offered free treatment?’ 
18 (62%) gave the same response at test and retest and 
10 (35%) answered correctly only at retest. For the item, 
‘Which describes one of the main risks involved in the study?’ 19 
(68%) gave the same answer at both time points, while 
6 (21%) answered correctly only at retest.
Among the five items for which correlation coefficients 
could not be obtained, 26 participants (90%) answered 
consistently at test and retest on the question: ‘Have you 
been told that you can freely decide whether you and your child 
will take part in this study?’ For the item, ‘Will you and your 
child be told the results of his or her HIV test results during the 
study?’ 28 participants (97%) answered consistently. For 
the open-ended item, ‘In your own words, can you tell me what 
makes you and your child eligible to participate in this study?’ 25 
participants (92%) answered consistently, and 26 partici-
pants (90%) answered consistently on the question: ‘How 
long will your child be involved in the study?’ For the open-
ended item: ‘What will you and your child be asked to do as 
participants in the study after he/she receives their test results?’ 
23 participants (79%) answered consistently at test and 
retest. Finally, with the negative correlation (−1.0) on the 
item, ‘What does it mean when you sign the consent form?’ 18 
parents were consistent at both time points while 10 went 
from incorrect at test to correct at retest.
DIsCussIOn
The DICCQ14 proved to be a useful prototype for adap-
tation with the Kenyan study. Although the parent study 
was very different from those for which the DICCQ 
was developed and included minor adolescents and 
their parents rather than solely adults, we found the 
comprehensive domain-linked questions highly useful 
for adaptation. Given the design of our study, we 
dropped questions related to clinical trials (blinding 
and placebo), revised questions related to specific study 
procedures and populations, and added items specific 
to assenting adolescents. Examination by bioethicists 
for face and content validity, as well as piloting with 
relevant local populations, led to further questionnaire 
revisions. The exercise also led us to clarify some of the 
information in the informed consent forms.
Psychometric testing (ceiling/floor) led us to modify 
the open-ended questions as multiple-choice items (see 
final ICCA versions in online supplementary appen-
dices). We recognise that open-ended items are ideally 
the better tool for testing comprehension, since partic-
ipants can guess multiple-choice answers correctly, thus 
inflating comprehension levels. Nevertheless, we found 
that writing down answers in their own words (or even 
telling staff their answers to write them down) was a 
Table 2 Ceiling and floor percentages by response group. 
Questions with more than 80% correct 
(ceiling) 
Adolescents (age 15–
17 years; n=107)
Young adults (age 
18–19 years; n=36) Parents (n=92)
  T-shirt for participation 93.5 97.2 80.4†
  Study activities for youth 91.6 91.7 N/A
  HIV test results disclosure 94.4 94.4 90.2
  Voluntary withdrawal N/A 94.4 85.9
  Decisions for study participation N/A 88.9 N/A
  What happens if you stop study participation N/A 86.1 N/A
  Purpose of conducting study N/A 88.9 N/A
  Voluntary participation N/A 100 93.5
Questions with less than 20% correct (floor) 
Adolescents (age 15–
17 years; n=107)
Young adults (age 
18–19 years; n=36) Parents (n=92)
  Mode of group selection 19.8 N/A 17.4†
  Study benefits 16.8 16.7 19.6†
  Research purpose (open)‡ 1.1 13.3 1.1
  Study duration (open)‡ 13.1 N/A 9.8
  What is next after HIV test results (open)‡ 14.0 N/A N/A
  Study HIV test versus clinic HCT (open)‡ 7.7 0 2.2
  Study risks (open)‡ 9.3 N/A 13.0
  Whom to call (open)‡ 10.5 19.4 19.6†
  Study eligibility (open)‡ N/A N/A 7.7
*Per cent only shown if ceiling/floor cut-off met.
†Parents who consented without staff present would not have met criterion for ceiling; parents who consented with staff would not meet 
criterion for floor.
‡(open) denotes open-ended questions, (response range=0–4). These were dichotomised for floor/ceiling analysis: 0=0–1, 1=2–4.
N/A, less than 80% of the sample (by population) got these items correct (upper panel) or incorrect (lower panel). 
HCT, HIV Counselling and Testing. 
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difficult and off-putting process, and required staff to 
parse out whether qualitative answers were partially 
right or wrong. Finally, test-retest correlations suggested 
moderate to strong temporal stability for items, despite 
limitations of small sample size and disparate modes of 
parental consenting.
Table 3 Test-retest correlations for questions common to all and specific to adolescents, young adults and parents (n=74)* 
Question N
Tetrachoric/
polychoric
Common to all
  Have you been given the name and phone number of the person to contact if you 
have any questions about the study?
74 0.86
  Will you receive a T-shirt for taking part in the study? 74 0.6
  How were participants selected into different groups in this study? 74 0.57
  In your own words, can you tell me what the purpose of the research study is? (open) 73 −0.92
  What is the difference between taking part in this study and going to the clinic for 
voluntary HIV testing? (open)
72 0.87
  Are there any bad things that could happen by taking part in this study? If yes, what 
are they? (open)
70 0.9
  If you had a question or concern about the study, who would you call? (open) 74 0.72
Young adults and adolescents
  Have you been told you can withdraw from the study at any time? 45 0.75
  During the study, will anyone not working with KEMRI or the nearest clinic know 
about your health information?
44 0.62
  At what point can you leave the study? 45 0.94
  What does it mean when you sign the study consent form?† 45 0.19
  What happens if you decide to stop taking part in the study? 45 0.86
  Which of the following describes best why the study is being done? 45 0.51
  Which of these activities were you asked to take part in today? 45 0.62
  Will you be told your HIV test results during the study?‡ 45 N/A
  Other activities you might be invited to do? 45 0.6
  If you test positive for HIV, will you be offered free treatments? 45 0.66
  If you are invited to participate in additional interviews for this study, how will you be 
compensated for your participation?
45 0.73
  Which describes one of the main risks involved in the study? 45 0.67
  Which describes the main benefit of taking part in the study?† 45 0.26
  In your own words, can you tell me what makes you eligible to participate in this 
study? (open)
45 0.9
  How long will you be involved in the study? (open) 45 0.86
  What will you be asked to do as a participant in the study after you receive your HIV 
test results? (open)†
45 0.47
Adolescents only
  If you want to join the study, but your parent/guardian does not agree, can you still 
join the study?
33 0.64
  If your parents wants you to join the study, but you do not want to, are you still 
allowed to refuse?†
33 0.45
Unique to young adults
  Have you been told that you can freely decide whether you will take part in this 
study?‡
12 N/A
  How did you decide to join the study?‡ 12 N/A
*Post hoc analysis with cross-tabulations were used to further explore the low correlation coefficient.
†A correlation coefficient could not be obtained for this item. Cross-tabulations were used to examine relationships within the data.
‡For complete questions with responses, see online supplementary appendix.
KEMRI, Kenya Medical Research Institute.
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Our study contributes to ethical discussions about 
informed consent in Africa in a number of ways. First, 
the value of a valid and adaptable tool to test comprehen-
sion of informed consent in African contexts should be 
emphasised and articulated. To improve comprehension, 
one needs an instrument that can reliably identify areas 
of substandard understanding. With this in hand, these 
specific areas can then be targeted for interventions. 
Simply rereading the entire consent document with the 
participant may not be enough; one may need instead 
to focus on certain areas (some perhaps specific to the 
particular study), ask the prospective participant ques-
tions and emphasise these areas in a subsequent revisiting 
of the consent process. Second, the comprehension tool 
could be feasible for research with human participants 
conducted in resource-constrained settings. The DICCQ 
is a free, open-source tool that researchers can adapt to 
their particular research context, although adaptation 
comes with some costs. In addition, one could recommend 
that the tool be used selectively, that is, in large-scale trials 
involving significant (greater than minimal) risk—where 
the stakes for valid informed consent are higher—rather 
than all studies involving human participants. These trials 
are also more likely than others to have sufficient human 
and other resources to absorb the costs of adapting and 
implementing the tool, and its use may be more easily 
integrated into standard operating procedures. It should 
be noted that some assessments and interventions can be 
relatively simple. In a prior study on adolescent percep-
tions of health services, we assessed the understanding of 
consent by asking six key questions, and selectively revis-
iting the consent process depending on the answers.32 
This enhanced consent process targeted adolescents 
who planned to participate in HIV-related studies where 
parental permission had been waived. Thirdly, the devel-
opment and use of the tool could have implications for 
the ethical review of research. If such tools are feasible 
and effective in raising comprehension scores, research 
ethics committees may recommend (or require) their use 
in the consent processes of (at least a subset of) research 
studies.
However, some important challenges regarding the use 
of comprehension assessment tools in consent remain. As 
some have noted, if full comprehension were a require-
ment for valid consent, and valid consent was necessary 
and sufficient for the ethics of research, all research studies 
involving human participants would likely be unethical.33 
It would be unreasonable—a form of 'research exception-
alism'34—to expect vastly higher levels of consent compre-
hension in research than in other comparable areas of 
human life. But how much less than full comprehen-
sion is 'good enough' for valid informed consent? When 
should the results of a comprehension assessment trigger 
the need for interventions to improve understanding?
It is understandable to want a quantifiable threshold of 
comprehension below which the consent of participants 
is invalidated. The threshold would provide an objec-
tive indicator of the need for interventions to improve 
understanding and also provide a goal for such inter-
ventions, that is, the intervention should raise compre-
hension to or above the accepted threshold. It would 
clearly be worrying, for example, if the comprehension 
tool revealed that only 5% of study participants under-
stood that they could leave the study at any time, for any 
reason. If there was an agreed-upon threshold of (say) 
65% for understanding that aspect of informed consent, 
researchers using the tool would know the magnitude of 
the problem and what to aim for.
However, questions remain about the attainability of 
such thresholds. First, such thresholds are likely to be 
affected by contextual factors. For example, it seems 
plausible that the threshold for understanding study 
risks should be higher when the risks are higher, and 
lower when they are lower. Other contextual factors may 
include the study population involved, nature of the 
research question or social value of the potential results. 
If this is the case, the acceptable threshold of compre-
hension would be a matter of context-sensitive judgement 
rather than an objective, quantifiable measure. However, 
comprehension assessment tools still have utility even if 
this is the case. Results of assessment can help inform 'all 
things considered' judgements about whether consent 
comprehension is adequate, particularly when assess-
ments are fine-grained and focus on specific key elements 
that participants should know. The tool allows researchers 
to stipulate and test for adequate levels of comprehension 
(say, 70%) on crucial aspects of research participation, 
providing research ethics committees with some confi-
dence that serious attention is being paid to this issue. 
Where to set these levels is likely to become clearer as 
the tool is used over time. In addition, interventions to 
improve baseline understanding retain their value even 
if objective thresholds of acceptable comprehension 
currently remain elusive. To use an analogy, tools to assess 
baseline understanding about HIV are valuable even if it 
is not entirely clear precisely how much you need to know 
to be a well-informed, responsible citizen.
Finally, for those concerned about quality of informed 
consent, it should be noted that informed consent is 
only one element among others in a suite of protections 
that should be offered to research participants. Even if 
comprehension seems less than ideal, a study may be 
morally acceptable if the research is responsibly designed 
and conducted in other respects.35 These consider-
ations notwithstanding, our study results reinforce calls 
to develop innovative and culturally responsive ways to 
present research-related information, beyond the stan-
dard method of reading consent forms.30 The impossi-
bility of perfect comprehension, as well as the elusiveness 
of objective thresholds of acceptable comprehension, 
should not be the enemy of comprehension assessment 
or evidence-based efforts to improve consent processes.
The study has a number of limitations. Rigorous 
psychometric testing was beyond the scope of our study 
and therefore face validation and expert evaluation were 
used. Sample size for validation was small, particularly 
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given the differences in instrumentation for our three 
populations. Ceiling and floor effects, while extensively 
limiting the item operational range, provided insight into 
item functioning and informed modifications needed 
for the ICCA response options, and the current data 
were recoded to reflect those needs. Further, for test-re-
test, we conducted the first ICCA immediately prior to the 
actual study procedures, and the second after the partic-
ipants had experienced these procedures, which likely 
influenced some of their answers at retest. Some parents 
were not available to meet with staff for consenting proce-
dures, leading to differences in the opportunity to hear 
the consent form read aloud and to ask questions of staff.
The paucity of similar African studies on instruments 
for informed consent comprehension is not surprising, 
given the cost and highly technical nature of psycho-
metric development and testing of a comprehension 
instrument. Given the difficulties, we found it exceed-
ingly useful to have a non-proprietary instrument that 
invited adaptation in other contexts. We also found the 
adaptation and validation process was helpful in further 
fine-tuning our instrument and our informed consent 
document, to make sure that we were fully and clearly 
communicating the information required for human 
subject protection. We include the final three documents 
in the online supplementary appendix in the hope that 
they will be useful to other researchers.
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